AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMRICOR MEDICAL SYSTEMS-CDI

1.450

+0.0654.69%

Volume:916.90K

Turnover:1.31M

Market Cap:519.89M

PE:-8.26

High:1.475

Open:1.400

Low:1.380

Close:1.385

52wk High:2.250

52wk Low:1.275

Shares:358.54M

Float Shares:275.05M

Volume Ratio:2.12

T/O Rate:0.33%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.176

EPS(LYR):-0.118

ROE:-143.12%

ROA:-26.53%

PB:12.48

PE(LYR):-12.34

Loading ...

Overview Company News Filings

Imricor Medical Systems Says FDA Completes Review of PMA Module Three

MT Newswires Live

Imricor Medical Systems - FDA Completes Review of Imricor's Third Pma Module

THOMSON REUTERS

Imricor Medical Systems - no Deficiencies Identified for Vision-Mr Ablation Catheter 2.0

THOMSON REUTERS

Imricor Medical Systems - Preparing Response to FDA for Module 3 Closure

THOMSON REUTERS

Imricor's Stock Weakness Creates 'Great Buying Opportunity'

Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module

Imricor Medical Systems, - FDA to Conduct Pre-Approval Inspection of Imricor's Manufacturing Sites

THOMSON REUTERS

Imricor Medical Systems, Inc-FDA Accepts Imricor Pma Manufacturing Module

THOMSON REUTERS

Imricor, Philips Collaborate on Interventional Magnetic Resonance Lab Product for Cardiac Intervention

MT Newswires Live

Imricor Medical Systems, Inc - Imricor and Philips Launch Commercial Imr Lab Solution

THOMSON REUTERS

Jarden Research Adjusts Imricor Medical Systems' Price Target to AU$3.35 from AU$3.30, Keeps at Buy

MT Newswires Live

Imricor Medical Systems Nears 'Genuine Commercial Inflection Point' After Two Decades of Platform Development, Jarden Says

MT Newswires Live

Imricor Medical Systems Q2 Loss Narrows, Revenue Down

MT Newswires Live

Imricor Medical Secures Second US Customer, Shares Up 3%

MT Newswires Live

Imricor Medical Systems - Anticipated FDA Clearances of Additional Capital Equipment Expected to Broaden Product Offering Available to U.S. Customers

THOMSON REUTERS

Imricor Says Philips Issues 'Third-Party Product Compatibility Declaration' for Its Interventional Magnetic Resonance Products

MT Newswires Live

Imricor Launches Cardiovascular Unit to Expand iMR Use in Cardiac Catheterization

MT Newswires Live

Imricor Medical Systems Hits 3-month High on Securing First US Hospital Customer

Imricor Medical Systems Begins US Commercial Launch with Sale of iMR Mapping, Guidance System

MT Newswires Live

Imricor Medical Systems, Inc-imricor Launches U.S. Commercial Operations

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigerhkgo.com/stock/IMR.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":1.45,"timestamp":1791781920000,"preClose":1.385,"halted":0,"volume":916897,"delay":0,"changeRate":0.046931407942238226,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":275046474,"shares":358542497,"eps":-0.17556109725685784,"marketStatus":"Closed","change":0.065,"latestTime":"10-12 16:12:00 AEDT","open":1.4,"high":1.475,"low":1.38,"amount":1314827,"amplitude":0.068592,"askPrice":1.51,"askSize":4062,"bidPrice":1.45,"bidSize":9280,"shortable":3,"etf":0,"ttmEps":-0.17556109725685784,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791846000000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":1.385,"openAndCloseTimeList":[[1791759600000,1791781200000]],"volumeRatio":2.122566,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMR.AU","preClose":1.385,"auctionPrice":1.45,"auctionVolume":19296,"auctionTime":1791781818141,"referencePrice":1.45,"referenceTime":1791782490799,"auction":3,"marketStatus":"盘后竞价","timestamp":1791781818141}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":275046474,"roa":"-26.53%","roe":"-143.12%","lyrEps":-0.117527,"volumeRatio":2.122566,"shares":358542497,"dividePrice":0,"high":1.475,"amplitude":0.068592,"preClose":1.385,"low":1.38,"week52Low":1.275,"pbRate":"12.48","psRate":"3020.94","week52High":2.25,"institutionHeld":0,"latestPrice":1.45,"committee":0.391096,"eps":-0.17556109725685784,"divideRate":0,"volume":916897,"delay":0,"ttmEps":-0.17556109725685784,"open":1.4,"prevYearClose":1.53,"prevWeekClose":1.385,"prevMonthClose":1.585,"prevQuarterClose":1.585,"fiveDayClose":1.55,"twentyDayClose":1.85,"sixtyDayClose":1.66,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-10","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786320000000,"name":null,"time":"","dateTimestamp":1786284000000,"actualEps":null},{"date":"2026-02-24","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2025-08-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673046364","title":"Imricor Medical Systems Says FDA Completes Review of PMA Module Three","url":"https://stock-news.laohu8.com/highlight/detail?id=2673046364","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673046364?lang=en_us&edition=fundamental","pubTime":"2026-10-08 07:41","pubTimestamp":1791416498,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said the US Food and Drug Administration has completed its review of module three of the company's premarket approval  submission, which covers non-clinical bench testing for its Vision-MR ablation catheter 2.0, RF-5000 system and irrigation tubing set, according to a Thursday Australian bourse filing.No deficiencies were identified in the catheter or tubing set, while one deficiency was found in the RF-5000 system's third-party software operating system, which the company has already upgraded to a long-term supported version, per the filing.The company is preparing its response to the FDA, with module three expected to close upon acceptance and module four targeted for submission in November, thereby completing all PMA submissions, the filing added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK7007","LABU","BK7508","BK4588","BK4129","BK7503","PMA","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673430360","title":"Imricor Medical Systems - FDA Completes Review of Imricor's Third Pma Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2673430360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673430360?lang=en_us&edition=fundamental","pubTime":"2026-10-08 06:18","pubTimestamp":1791411483,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45T23P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7503","BK7007","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673043039","title":"Imricor Medical Systems - no Deficiencies Identified for Vision-Mr Ablation Catheter 2.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2673043039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673043039?lang=en_us&edition=fundamental","pubTime":"2026-10-08 06:18","pubTimestamp":1791411483,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45T23P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7007","IMR.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673031043","title":"Imricor Medical Systems - Preparing Response to FDA for Module 3 Closure","url":"https://stock-news.laohu8.com/highlight/detail?id=2673031043","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673031043?lang=en_us&edition=fundamental","pubTime":"2026-10-08 06:18","pubTimestamp":1791411483,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45T23P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7508","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672710738","title":"Imricor's Stock Weakness Creates 'Great Buying Opportunity'","url":"https://stock-news.laohu8.com/highlight/detail?id=2672710738","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672710738?lang=en_us&edition=fundamental","pubTime":"2026-10-01 07:18","pubTimestamp":1790810280,"startTime":"0","endTime":"0","summary":"2318 GMT - A more than 20% fall in the share price of Imricor Medical Systems since it entered the ASX 300 index in early September creates a great buying opportunity for investors, according to its bull at Morgans. Imricor ended Wednesday at A$1.585, having traded as high as A$2.07 in August. Morgans suggests seasonal weakness and rising interest rates may have contributed to the share-price fall. Recent news flow has been positive. \"As we move into a seasonally stronger part of the year, together with our view that material news flow  is expected, we believe the share price should move back over A$2.00,\" Morgans' analyst Scott Power says. Morgans has a speculative buy call on Imricor.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7503","IMR.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664842977","title":"Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2664842977","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664842977?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:46","pubTimestamp":1788392770,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing ModuleSept 3 -Imricor Medical Systems, IncIMR.AX:IMRICOR MEDICAL SYSTEMS, INC-FDA ACCEPTS IMRICOR PMA MANUFACTURING MODULEIMRICOR MEDICAL SYSTEMS, - FDA ACCEPTS AND CLOSES IMRICOR'S PMA MANUFACTURING MODULEIMRICOR MEDICAL SYSTEMS, - FDA TO CONDUCT PRE-APPROVAL INSPECTION OF IMRICOR'S MANUFACTURING SITESFurther company coverage:IMR.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUEBD40TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7007","IMR.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844156","title":"Imricor Medical Systems, - FDA to Conduct Pre-Approval Inspection of Imricor's Manufacturing Sites","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844156?lang=en_us&edition=fundamental","pubTime":"2026-09-03 06:21","pubTimestamp":1788387678,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUEBD40TZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7503","BK7007","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664784413","title":"Imricor Medical Systems, Inc-FDA Accepts Imricor Pma Manufacturing Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2664784413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664784413?lang=en_us&edition=fundamental","pubTime":"2026-09-03 06:21","pubTimestamp":1788387678,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUEBD40TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7508","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662315210","title":"Imricor, Philips Collaborate on Interventional Magnetic Resonance Lab Product for Cardiac Intervention","url":"https://stock-news.laohu8.com/highlight/detail?id=2662315210","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662315210?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:18","pubTimestamp":1787872683,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems (ASX:IMR) collaborated with Royal Philips to offer an interventional magnetic resonance lab product for cardiac interventions, combining Philips' 1.5T magnetic resonance imagin","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","IMR.AU","BK7508","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662003626","title":"Imricor Medical Systems, Inc - Imricor and Philips Launch Commercial Imr Lab Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2662003626","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662003626?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:17","pubTimestamp":1787869025,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1PA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMR.AU","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658918639","title":"Jarden Research Adjusts Imricor Medical Systems' Price Target to AU$3.35 from AU$3.30, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658918639","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658918639?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:13","pubTimestamp":1786443206,"startTime":"0","endTime":"0","summary":"Jarden Research Adjusts Imricor Medical Systems' Price Target to AU$3.35 from AU$3.30, Keeps at Buy","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK7508","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658961945","title":"Imricor Medical Systems Nears 'Genuine Commercial Inflection Point' After Two Decades of Platform Development, Jarden Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658961945","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658961945?lang=en_us&edition=fundamental","pubTime":"2026-08-11 12:50","pubTimestamp":1786423845,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems (ASX:IMR) is nearing a \"genuine commercial inflection point\" as it transforms almost two decades of platform development into a recurring, high-margin revenue stream, Jarden sa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK7508","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658604264","title":"Imricor Medical Systems Q2 Loss Narrows, Revenue Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2658604264","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658604264?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:50","pubTimestamp":1786333848,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems'  second-quarter net loss was $7.4 million, compared with $7.8 million in the prior-year quarter, according to a Monday Australian bourse filing.Revenue for the three months ended June 30 came in at $60,500, compared with $65,200 in the year-ago period, the medical device company said.The company said it is expanding its US commercial team, with additional hires to be added during the September and December quarters to cover new regions of the US.Imricor Medical Systems' shares rose nearly 3% in recent trading on Monday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","IMR.AU","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658609876","title":"Imricor Medical Secures Second US Customer, Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658609876","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658609876?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:34","pubTimestamp":1786325656,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  secured its second customer in the US, with Children's Medical Center, Dallas, in Texas purchasing its NorthStar interventional magnetic resonance  mapping and guidance system, according to a Monday Australian bourse filing.The hospital has an existing Philips magnetic resonance lab, which means no lab construction will be required, and procedures guided with the system can begin following installation. Children's Medical Center Dallas will launch a NorthStar-guided interventional magnetic resonance cardiac catheterization program.Its shares rose 3% in recent trading on Monday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK7508","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658603967","title":"Imricor Medical Systems - Anticipated FDA Clearances of Additional Capital Equipment Expected to Broaden Product Offering Available to U.S. Customers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658603967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658603967?lang=en_us&edition=fundamental","pubTime":"2026-08-10 06:39","pubTimestamp":1786315198,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260809:nFWN44603C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","IMR.AU","BK7508","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657644676","title":"Imricor Says Philips Issues 'Third-Party Product Compatibility Declaration' for Its Interventional Magnetic Resonance Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644676","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657644676?lang=en_us&edition=fundamental","pubTime":"2026-08-07 08:03","pubTimestamp":1786060983,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said Philips Medical Systems Nederland issued a \"Third-Party Product Compatibility Declaration,\" covering Imricor's interventional magnetic resonance products when used with Philips' magnetic resonance systems, according to a Friday Australian bourse filing.This will allow Imricor's NorthStar mapping and guidance system to connect and operate in a commercial clinical setting with Philips magnetic resonance scanners.The declaration covers five initial magnetic resonance systems and four magnetic resonance system upgrades running software versions R12.1.1 or greater.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7007","BK7503","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656895300","title":"Imricor Launches Cardiovascular Unit to Expand iMR Use in Cardiac Catheterization","url":"https://stock-news.laohu8.com/highlight/detail?id=2656895300","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656895300?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:07","pubTimestamp":1785794846,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  launched Imricor Cardiovascular, a new business vertical designed to broaden the application of interventional magnetic resonance  in cardiac catheterization alongside its existing electrophysiology and ablation portfolio, according to a late Monday statement by the company.The platform enables US hospitals to perform radiation-free cardiac catheterization by integrating magnetic resonance imaging and catheterization into a single procedure.The approach is expected to shorten procedure time for each patient by around 35%, enhancing hospital efficiency while increasing available capacity in X-ray catheterization laboratories.The company said the technology particularly benefits pediatric and congenital heart patients by enabling repeated catheterizations without ionizing radiation while improving imaging and reducing anesthesia use.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","CSII","BK7007","BK4082","BK7508","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654980830","title":"Imricor Medical Systems Hits 3-month High on Securing First US Hospital Customer","url":"https://stock-news.laohu8.com/highlight/detail?id=2654980830","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654980830?lang=en_us&edition=fundamental","pubTime":"2026-07-27 09:15","pubTimestamp":1785114926,"startTime":"0","endTime":"0","summary":"BUZZ-Imricor Medical Systems hits 3-month high on securing first US hospital customer** Imricor Medical Systems'IMR.AXshares rise as much as 9.9% to A$2.11, highest level since April 23** Medical tech company launches U.S. commercial operations and secures first hospital customer** Rady Children's Hospital in San Diego will purchase Imricor's NorthStar iMR mapping and guidance system, becoming the company's first commercial customer in the U.S.** About 769,000 shares change hands, 2.1x the 30-day average volume** Including session moves, stock up 30.1% this year","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL4N43T02B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7508","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654060709","title":"Imricor Medical Systems Begins US Commercial Launch with Sale of iMR Mapping, Guidance System","url":"https://stock-news.laohu8.com/highlight/detail?id=2654060709","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654060709?lang=en_us&edition=fundamental","pubTime":"2026-07-27 08:18","pubTimestamp":1785111524,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  began its official US commercial launch, with the Rady Children's Hospital in San Diego, California, purchasing its NorthStar interventional magnetic resonance  mapping and guidance system, according to a Monday Australian bourse filing.It also launched a new vertical, Imricor Cardiovascular, for the NorthStar system. It expects to continue adding devices and applications within the Cardiovascular business over time.Several US hospitals are in the final stages of the purchasing process, the filing added. Revenue from the NorthStar sales is expected to exceed the European business' aggregate full-year revenue in 2025.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7007","IMR.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654067940","title":"Imricor Medical Systems, Inc-imricor Launches U.S. Commercial Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2654067940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654067940?lang=en_us&edition=fundamental","pubTime":"2026-07-27 06:34","pubTimestamp":1785105288,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260726:nTUEBTLYG8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7503","BK7007","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}]}}